(Press-News.org) Popular anti-obesity drugs continue to show cardiovascular benefits beyond weight loss, according to several new papers published in JACC, the flagship journal of the American College of Cardiology, that are being simultaneously presented at the American Heart Association’s 2024 Scientific Sessions. JACC is publishing two secondary analyses on the impact of GLP-1 medications in improving cardiac structure and function in heart failure patients and cardiovascular outcomes in those who previously had cardiac bypass surgery, plus a new analysis of a lifestyle intervention trial showing that cardiac risk biomarkers change with weight loss.
“These studies reinforce the potential of GLP-1-based therapies not only to aid in weight loss but also to transform cardiac health, offering hope for patients living with obesity and cardiovascular disease,” said Harlan M. Krumholz, MD, SM, editor-in-chief of JACC and the Harold H. Hines Jr Professor of Medicine at Yale University School of Medicine. “As the science evolves, we are achieving a deeper understanding of how weight loss, and treatment with these medications, can improve outcomes across diverse patient populations with obesity.”
Tirzepatide Decreases Heart Size to Improve Cardiac Structure, Function
In a secondary analysis of the SUMMIT trial, researchers looked at the effect of the combined GLP-1 and GIP receptor agonist tirzepatide on cardiac structure and function in patients with heart failure with preserved ejection fraction (HFpEF) and obesity. Tirzepatide has already been FDA approved for weight loss. Researchers looked at 106 patients from the main SUMMIT study who underwent imaging to analyze left ventricular (LV) mass and epicardial adipose tissue (EAT) at baseline and 52 weeks. Results showed that tirzepatide decreased LV mass by 11 g and decreased paracardiac adipose tissue by 45 ml in the treated group compared to the placebo group. EAT decreased in both groups. According to researchers, the decrease in heart size may be a contributing factor in the reduction in heart failure events seen in the main SUMMIT trial, which was also presented at AHA 2024 Scientific Sessions.
Semaglutide Improved Cardiac Outcomes in Patients Who Had Cardiac Bypass Surgery
In a secondary analysis of the SELECT trial, patients who already had cardiac bypass surgery and are living with obesity or overweight but not diabetes were randomized to receive once-weekly semaglutide or placebo to determine if it improved cardiac outcomes. This patient population is at a higher risk of persistent ischemic events, heart failure and death, but there is little data on how to improve secondary outcomes in these patients after heart surgery. In the analysis, 2,057 participants had a history of CABG and 15,547 did not. Those with CABG were older (65 years old vs. 61 years old), 84% were male vs. 70%, 2.1% were Black vs. 4%, and they had a lower BMI (31.9 kg/m2 vs. 32.1 kg/m2). Semaglutide led to a consistent reduction in major adverse cardiovascular events in both groups, but the absolute risk reduction with semaglutide was greater in those with a history of CABG (2.3% vs. 1%). Semaglutide was also shown to reduce the incidence of diabetes in the CABG group.
Weight Loss Via Lifestyle Intervention Can Change Cardiac Biomarkers
A secondary analysis of the LookAHEAD trial showed that lifestyle interventions targeting weight loss for Type 2 Diabetes patients led to a change in biomarkers associated with higher risk of cardiovascular disease and heart failure. Cardiac biomarkers are measured to determine if people with Type 2 diabetes are at elevated risk for developing heart failure. It is known that weight loss and exercise can reduce risk for cardiovascular disease, but less is known about changes in biomarkers. Researchers found that lifestyle interventions led to sustained reductions in high-sensitivity cardiac troponin T (hs-cTnT) at one and four years follow up and a rise in N-terminal pro-B-type natriuretic peptide (NT-proBNP) at one year attenuated at four years. Changes in these biomarkers are clinically relevant for patients with Type 2 diabetes, as the researchers found that patients with elevated NT-proBNP and hscTnT were at greater risk of future ASCVD, and that patients with elevated NT-proBNP were also at greater risk of developing HF.
For copies of the manuscripts, contact ACC Director of Media Relations Nicole Napoli at nnapoli@acc.org.
For all the latest GLP-1RA-related articles published by JACC, visit http://www.jacc.org/special-collection/obesity.
The American College of Cardiology (ACC) is the global leader in transforming cardiovascular care and improving heart health for all. As the preeminent source of professional medical education for the entire cardiovascular care team since 1949, ACC credentials cardiovascular professionals in over 140 countries who meet stringent qualifications and leads in the formation of health policy, standards and guidelines. Through its world-renowned family of JACC Journals, NCDR registries, ACC Accreditation Services, global network of Member Sections, CardioSmart patient resources and more, the College is committed to ensuring a world where science, knowledge and innovation optimize patient care and outcomes. Learn more at www.ACC.org or follow @ACCinTouch.
The ACC’s JACC Journals rank among the top cardiovascular journals in the world for scientific impact. The flagship journal, the Journal of the American College of Cardiology (JACC) — and specialty journals consisting of JACC: Advances, JACC: Asia, JACC: Basic to Translational Science, JACC: CardioOncology, JACC: Cardiovascular Imaging, JACC: Cardiovascular Interventions, JACC: Case Reports, JACC: Clinical Electrophysiology and JACC: Heart Failure — pride themselves on publishing the top peer-reviewed research on all aspects of cardiovascular disease. Learn more at JACC.org.
###
END
Anti-obesity drugs, lifestyle interventions show cardiovascular benefits beyond weight loss
New JACC studies show benefits in improving in cardiac structure and function and in CABG patients, plus cardiac risk biomarker changes with lifestyle interventions
2024-11-18
ELSE PRESS RELEASES FROM THIS DATE:
Oral muvalaplin for lowering of lipoprotein(a)
2024-11-18
About The Study: Muvalaplin, an oral small molecule lipoprotein(a) inhibitor, reduced lipoprotein(a) measured using intact lipoprotein(a) and apolipoprotein(a)-based assays and was well tolerated. The effect of muvalaplin on cardiovascular events requires further investigation.
Corresponding Author: To contact the corresponding author, Stephen J. Nicholls, MBBS, PhD, email stephen.nicholls@monash.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2024.24017)
Editor’s Note: Please see the article for additional information, including ...
Revealing the hidden costs of what we eat
2024-11-18
(Santa Barbara, Calif.) — Shifting our diets to be more sustainable can be a powerful way for each of us to address both climate change and global food insecurity, however making such adjustments at the large scales necessary to make a difference globally can be a delicate matter.
“Changes in food demand in one part of the world can have cascading environmental and human welfare implications for people around the world),” said Joe DeCesaro, data analyst at UC Santa Barbara’s National Center for Ecological Analysis & Synthesis (NCEAS).
Despite the seemingly daunting complexity of the global food system, to ensure a healthy population ...
New therapies at Kennedy Krieger offer effective treatment for managing Tourette syndrome
2024-11-18
BALTIMORE, November 18, 2024— Researchers at Kennedy Krieger Institute have made significant strides in improving the lives of patients with Tourette syndrome. Their recent publication highlights how behavioral therapies—an approach that teaches patients how to manage certain tics using behavioral strategies—are proving to be the most effective treatment.
Tourette syndrome (TS), a neurodevelopmental disorder affecting up to 1% of the population, is characterized by motor and vocal tics, which are sudden, repetitive movements or sounds that can significantly ...
American soil losing more nutrients for crops due to heavier rainstorms, study shows
2024-11-18
UNIVERSITY PARK, Pa. — Phosphorus, a nutrient in soil essential for sustaining most forms of life, is increasingly disappearing from land as it is washed into waterways throughout the United States, according to a new study led by researchers at Penn State.
The study, published today (Nov. 18) in the Proceedings of the National Academy of Sciences, analyzed data from 430 rivers across the U.S. and found that phosphorus loss from agricultural lands has increased over the past four decades, despite efforts to reduce it. This loss of phosphorus ...
With new imaging approach, ADA Forsyth scientists closely analyze microbial adhesive interactions
2024-11-18
Cambridge, Mass., 11/18/2024 – Scientists have identified many types of bacteria in the mouth, but many problems remain in understanding how they work with one another. One of the problems is that microbes assemble themselves into densely packed multi-species biofilms. Their density and complexity pose acute difficulties for visualizing individual cells and analyzing their interactions at single-cell level.
ADA Forsyth scientists have developed a new imaging approach that makes it possible to analyze the spatial connections between bacteria, including the strength of adhesive forces that hold them together. Adhesion is of fundamental importance in ...
Global antibiotic consumption has increased by more than 21 percent since 2016
2024-11-18
Washington, DC / Bangalore, India — A new study highlights recent, but fluctuating, growth in global human antibiotic consumption, one of the main drivers of growing antimicrobial resistance (AMR). AMR results in infections that no longer respond to antibiotics (and other antimicrobial medicines) and often leads to longer hospital stays, higher treatment costs, and higher mortality rates. AMR is estimated to be associated with nearly five million global deaths annually.
Researchers affiliated with the One Health Trust (OHT), the Population Council, GlaxoSmithKline, the University of Zurich, the University of Brussels, ...
New study shows how social bonds help tool-using monkeys learn new skills
2024-11-18
The research team, led by Durham University’s Department of Anthropology, studied two groups of wild bearded capuchin monkeys in Brazil’s Serra da Capivara National Park.
The researchers installed a large box in the park which contained food that the monkeys could access by either lifting a door or pulling a knob.
The team observed which monkeys learned how to access the food, and how that information then spread to the rest of their group.
The researchers specifically focused on the role played by social tolerance in the learning of the problem-solving behaviour.
Social tolerance determines who is allowed ...
Modeling and analysis reveals technological, environmental challenges to increasing water recovery from desalination
2024-11-18
Climate change is making water scarcer. A promising method to combat this problem is desalination technology because it can tap seawater. Though desalination has potential, it also brings risks with environmental impact, cost, and accessibility. Zero liquid discharge (ZLD) technology aims to increase water recovery from desalination by squeezing more water out of desalination brine. ZLD can help reduce water scarcity and waste from desalination plants, but comes at increased costs and, potentially, increased environmental effects from desalination.
In ...
Navy’s Airborne Scientific Development Squadron welcomes new commander
2024-11-18
WASHINGTON — Cmdr. J. Aaron Roberts relinquished command of the U.S. Naval Research Laboratory’s (NRL) Scientific Development Squadron (VXS) 1, the Warlocks, to Cmdr. Luis A. Levine, the new Commanding Officer (CO), during a change of command and retirement ceremony Nov. 14 at Naval Air Station (NAS) Patuxent River, Maryland.
NRL’s CO Capt. Jesse Black presented Roberts with the Meritorious Service Medal. Roberts served as the VXS-1 CO from May 2023 to November 2024 and the U.S. Navy for 21 years. Black said Roberts’ distinguished leadership was instrumental to the squadron’s continued record of exceptional support to NRL’s airborne ...
TāStation®'s analytical power used to resolve a central question about sweet taste perception
2024-11-18
PHILADELPHIA, PA – November 18, 2024 – Opertech Bio, Inc., a leading innovator in taste assessment, today announced the publication of a research article in which the TāStation® rapid throughput taste evaluation system was used to resolve a central question about sweet taste perception.
It has been well established that sweeteners impart their taste by activating the TAS1R2/TAS1R3 “sweet taste receptor” in the tongue. A second signaling pathway involving the activity of glucose transporters, operating independently of the receptor, recently has been proposed for metabolizable caloric sweeteners. In a powerful demonstration of the analytical ...
LAST 30 PRESS RELEASES:
Scientists unlock secrets behind flowering of the king of fruits
Texas A&M researchers illuminate the mysteries of icy ocean worlds
Prosthetic material could help reduce infections from intravenous catheters
Can the heart heal itself? New study says it can
Microscopic discovery in cancer cells could have a big impact
Rice researchers take ‘significant leap forward’ with quantum simulation of molecular electron transfer
Breakthrough new material brings affordable, sustainable future within grasp
How everyday activities inside your home can generate energy
Inequality weakens local governance and public satisfaction, study finds
Uncovering key molecular factors behind malaria’s deadliest strain
UC Davis researchers help decode the cause of aggressive breast cancer in women of color
Researchers discovered replication hubs for human norovirus
SNU researchers develop the world’s most sensitive flexible strain sensor
Tiny, wireless antennas use light to monitor cellular communication
Neutrality has played a pivotal, but under-examined, role in international relations, new research shows
Study reveals right whales live 130 years — or more
Researchers reveal how human eyelashes promote water drainage
Pollinators most vulnerable to rising global temperatures are flies, study shows
DFG to fund eight new research units
Modern AI systems have achieved Turing's vision, but not exactly how he hoped
Quantum walk computing unlocks new potential in quantum science and technology
Construction materials and household items are a part of a long-term carbon sink called the “technosphere”
First demonstration of quantum teleportation over busy Internet cables
Disparities and gaps in breast cancer screening for women ages 40 to 49
US tobacco 21 policies and potential mortality reductions by state
AI-driven approach reveals hidden hazards of chemical mixtures in rivers
Older age linked to increased complications after breast reconstruction
ESA and NASA satellites deliver first joint picture of Greenland Ice Sheet melting
Early detection model for pancreatic necrosis improves patient outcomes
Poor vascular health accelerates brain ageing
[Press-News.org] Anti-obesity drugs, lifestyle interventions show cardiovascular benefits beyond weight lossNew JACC studies show benefits in improving in cardiac structure and function and in CABG patients, plus cardiac risk biomarker changes with lifestyle interventions